Rosina Maar Pavia

Prior to joining Pappas in 2000, Dr. Pavia held senior management positions at contract research organizations for seven years, including as Vice President, Clinical Operations and Senior Vice President, Strategic Planning for Quintiles Transnational Corporation.
She managed the global clinical development program of Actonel, and oversaw the clinical components of projects leading to the approval of Actos, Aggrastat, Reopro, and Xeloda.
Dr. Pavia is the founder and Managing Director of StratWorks, LLC, a strategic consulting company focused on assisting biopharmaceutical companies with strategy, M&A, product acquisition and product development.
Previously, she was the Corporate Medical Director of a biotechnology company specializing in oncology immunotherapies.
Dr. Pavia received her board certification by the American Board of Internal Medicine in 1993.
Dr. Pavia received her BS in Health System from the School of Industrial Engineering at the Georgia Institute of Technology, her MD from the Morehouse School of Medicine, and her Executive MBA from the Kenan-Flagler Business School of the University of North Carolina at Chapel Hill.
She completed her post-doctorate training in Internal Medicine at Emory University.